Yorifuji-Okuno syndrome
Overview
Yorifuji-Okuno syndrome (pancreatic hypoplasia-diabetes-congenital heart disease syndrome) is an extremely rare genetic disorder characterized by the triad of underdeveloped pancreas (pancreatic hypoplasia), neonatal/early-onset diabetes mellitus, and congenital heart defects. It is an autosomal dominant condition linked to GATA6 gene mutations, often causing severe, life-limiting health issues from infancy, though some cases may have varied severity.
Symptoms
Neonatal/Early-Onset Diabetes: Severe hyperglycemia and diabetes mellitus resulting from a lack of insulins.
Pancreatic Hypoplasia/Agenesis: Underdevelopment or absence of the pancreas, leading to endocrine (insulin) and sometimes exocrine (digestive enzyme) insufficiency.
Congenital Heart Defects: Common defects include ventricular or atrial septal defects, transposition of the great vessels, patent ductus arteriosus, and pulmonary stenosis.
Other Potential Anomalies: Cases may include intrauterine growth retardation, failure to thrive, and sometimes neurological issues like microcephaly.
Causes
GATA6 Mutations: The primary cause is a mutation in the GATA6 gene, which is critical for the development of endodermally derived organs, including the heart, pancreas, and lungs.
Specific Genetic Defect: A specific 2-bp deletion (1504delAA) in exon 4 of the GATA6 gene was identified in the originally described Japanese family, affecting protein DNA-binding capacity's.
Inheritance Pattern: It is inherited as an autosomal dominant trait, meaning a mutation in only one copy of the gene is necessary to cause the disorders.
Inherited or De Novo: The mutation can be inherited from an affected parent or occur as a new (de novo) mutation in the child.
Mechanism: The defect leads to pancreatic hypoplasia (underdevelopment of the pancreas) and severe heart defects, including ventricular or atrial septal defects and patent ductus arteriosus.
Risk Factors
Genetic Mutation (\(GATA6\)): The syndrome is linked to heterozygous mutations in the \(GATA6\) gene on chromosome 18q11. This gene is crucial for the development of endodermally derived organs, including the heart and pancreas.
Autosomal Dominant Inheritance: It is passed down through families in an autosomal dominant manner, meaning a child has a 50% chance of inheriting the mutation if one parent has it.
Family History: A parent with pancreatic hypoplasia, congenital heart disease, or neonatal diabetes, especially if they are of Japanese descent, represents a major risk factor, based on the initial identification of the syndrome in a Japanese family.
Complications
Diabetes Mellitus: Permanent, early-onset diabetes requiring lifelong management due to inadequate insulin production.
Pancreatic Insufficiency: Lack of digestive enzymes, which can lead to malabsorption, nutritional deficiencies, and failure to thrive.
Congenital Heart Defects: Specific defects identified in cases include:
Transposition of the great vessels Ventricular or atrial septal defects Pulmonary stenosis Patent ductus arteriosus
Additional Reported Anomalies: Associated issues can include biliary atresia, diaphragmatic hernia, intestinal malrotation, microcephaly, or inguinal hernia.
The syndrome is generally inherited in an autosomal dominant manner, often linked to mutations in the GATA6 gene
Diagnosis
Genetic Testing: Diagnosis is confirmed by identifying heterozygous mutations in the GATA6 gene on chromosome 18q11.2, which is crucial for pancreatic development.
Imaging (Heart & Pancreas): Echocardiograms are essential for identifying associated congenital heart defects, including ventricular/atrial septal defects, pulmonary stenosis, or transposition of the great vessels. Imaging of the abdomen may reveal a small or underdeveloped pancreas (hypoplasia).Endocrine Function Tests: Blood tests assess for neonatal or early-onset diabetes mellitus resulting from a lack of insulin-producing pancreatic tissue.
Clinical Presentation: Diagnosis is often suspected in neonates presenting with severe diabetes and cardiac issues.
Treatment
Diabetes Management: Daily subcutaneous insulin is essential for managing hyperglycemia.
Pancreatic Enzyme Replacement: Patients with exocrine pancreatic insufficiency require lipase and other enzymes to improve nutrient absorption and manage failure to thrive.
Heart Defect Care: Cardiac anomalies, such as ventricular septal defects or patent ductus arteriosus, require specialized, and sometimes surgical, care.
Nutrition Support: High-calorie, fat-soluble vitamin supplements, and sometimes specialized formulas (e.g., medium-chain triglycerides), are necessary to ensure proper nutrition.
Supportive Care: Regular monitoring of growth, development, and blood glucose levels is essential for long-term management.
Type of Doctor Department : Pediatric Endocrinologist
.jpg)
Comments
Post a Comment